Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases.

See our vision & mission and objectives.

For the last fifteen years, we have worked together with our donors and partners to develop new medicines for vulnerable and poor communities.


DNDi is working on the following diseases:

Malaria Icon

Malaria
Portfolio handed over in 2015


GARDP IconIn 2016, in collaboration with the World Health Organization, DNDi launched the Global Antibiotic Research & Development Partnership (GARDP), a not-for-profit research and development organization to develop new antibiotic treatments addressing antimicrobial resistance and to promote their responsible use for optimal conservation, while ensuring equitable access for all.

 


20 entirely new chemical entities (NCEs) in the pipeline

About 240 staff
Half in endemic countries
1,255 people working on DNDi projects